Coherent Again Favors Revised Purchase Offer from II-VI - IDEX Health & ScienceIDEX Health & Science

    Disclaimer:

    The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.

    Coherent Again Favors Revised Purchase Offer from II-VI

    Article obtained from Photonics RSS Feed.

    Coherent has again determined that a revised acquisition proposal from II-VI is superior to terms of an amended merger agreement with Lumentum. Coherent has informed Lumentum that it intends to terminate that merger agreement, into which the companies entered on March 9 (announced on March 10), should it not receive an amended agreement.

    Terms of the new II-VI proposal, which is the fourth that Coherent has confirmed from II-VI, dictate that Coherent shareholders would receive $220 in cash and 0.91 of a share of Coherent common stock for each Coherent share.

    The deal is worth approximately $7 billion.

    The latest II-VI offer is in response to Coherent’s confirmation that it received, and that its board was…

    READ MORE
    Mar, 18 2021 |

    IDEX Health & Science is the global authority in fluidics and optics, bringing to life advanced optofluidic technologies with our products, people, and engineering expertise. Intelligent solutions for life.